FTY720 treatment partially reversed the antitumor effect of anti–PD-1 plus anti–CTLA-4 (Figure 5B) without influencing body weight (Supplemental Figure 11), demonstrating the role of CTL tumor infiltration in the antitumor effects of ICIs. The gene discussed is PDCD1; the disease is neoplasm.